ÂÜÀòÂÒÂ×

Chris Roth is the Vice President of Research and Vice President of Innovation at Abilita Therapeutics, Inc. Chris has experience as a Biotechnology Consultant and as a Research Scientist at Receptos, Inc. Chris also worked as a Post Doctoral Scientist at The Scripps Research Institute. Chris provides scientific guidance to the research organization and leads efforts in advancing protein engineering technologies for therapeutic discovery.